DuPont Spinoff Chemours Seen As Facing Rocky Start, But Turnaround Could Pay Off

Since Chemours shares began trading on the New York Stock Exchange on a ‘when issued’ basis on Friday, they’ve fallen nearly 18%. That drop has cut into DuPont’s stock, which is off, nearly 4% since Thursday’s close.